Bioorganic and Medicinal Chemistry Letters p. 2100 - 2106 (2019)
Update date:2022-08-04
Topics:
Harada, Kazuhito
Mizukami, Jun
Watanabe, Takashi
Mori
Ubukata, Minoru
Suwa, Katsunori
Fukuda, Sumiaki
Negoro, Tamotsu
Sato, Motohide
Inaba, Takashi
We describe here a novel GPR119 agonist 24, which showed a potent and long-acting hypoglycemic effect in rats via oral dosing. For the discovery of 24, we chose compound 5, which possessed an oxadiazole linker, as a lead compound among our spirocyclic cyclohexane GPR119 agonist series, taking into account its lower plasma protein binding nature. 3,5-Difluoro and 4-methylsulfonylmethy groups on the left side phenyl group, and a gem-difluoro group on the right side of 24 are important for its agonist potency and metabolic stability, respectively.
View MoreNantong Kaixin Pharma Chemical Co.,Ltd.
Contact:86-513-85250786
Address:2-1103 Huachen Mansion, 111 Gongnong Road,Nantong, Jiangsu, China
Beijing ZhongDaXinHe Chemical Product Co.,Ltd(expird)
Contact:010-52876516
Address:tongzhoubeiyuan
Contact:+86-025-52406782
Address:8 Taizishan Rd., Yanjiang Industrial Development Area, Nanjing, Jiangsu, China.
Tianjin Emulsion Science&Technology Development Co.,Ltd
Contact:13901380442
Address:Vake Garden New Town New Yi Bai Road Beichen District Tianjin,China
Beijing Mediking Biopharm Co., Ltd.
Contact:+86-10-89753524/81760121/81769521
Address:Hongxianghong Incubator, Beiqijia Town, Changping district, Beijing, China
Doi:10.1016/0040-4020(82)80110-5
(1982)Doi:10.1055/s-1976-24193
(1976)Doi:10.1021/jo01059a023
(1962)Doi:10.1016/S0008-6215(00)82362-9
(1974)Doi:10.1002/chem.201804455
(2018)Doi:10.1007/s00044-019-02310-y
(2019)